慢性淋巴细胞白血病治疗进展

Treatment progress of chronic lymphocytic leukemia

慢性淋巴细胞白血病(CLL)是一种慢性B淋巴细胞增殖性疾病。目前临床上常用的治疗方案(如FCR、BR、伊布替尼等)已取得了较好的疗效,但仍有患者面临疾病复发和进展。为进一步提高疗效,新型的针对CLL联合治疗方案不断涌现。文章结合第62届美国血液学会年会相关报道对CLL的最新治疗进展进行总结。

Chronic lymphocytic leukemia(CLL)is a kind of B-cell chronic lymphoproliferative disease.At present,the common clinical treatment regimens(such as FCR,BR,ibrutinib,etc.)have showed good therapeutic effects,but recurrence and progression still occur in some patients.In order to further improve the efficacy,the new combination therapies for CLL are continuously emerging.This article summarizes the treatment progress of CLL in combination with the related reports at the 62nd American Society of Hematology Annual Meeting.